Phase 2 Study of CAN008 in Subjects With GBM

Clinical trial NCT05447195 · UNKNOWN

Trial details

NCT number: NCT05447195
Sponsor: CANbridge Life Sciences Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Newly-diagnosed Glioblastoma

Start date: 2021-10-10
Primary completion: 2024-01-31
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.